logo
Plus   Neg
Share
Email

Harley-Davidson Announces Equity Investment In Alta Motors - Quick Facts

Harley-Davidson, Inc. (HOG) announced Thursday that it has made an equity investment in California-based Silicon-Valley startup Alta Motors, a leader and innovator in lightweight electric vehicles. The two companies will collaborate on electric motorcycle technology and new product development.

"Earlier this year, as part of our 10-year strategy, we reiterated our commitment to build the next generation of Harley-Davidson riders, in part, by aggressively investing in electric vehicle (EV) technology," said Harley-Davidson President and CEO Matt Levatich.

Harley-Davidson has already announced the planned launch of its first electric motorcycle, informed by Project LiveWire. The motorcycle is on track for release in 2019.

Alta Motors, formerly known as BRD Motorcycles, is a global leader in electric motorcycles and lightweight EV drivetrains with a proprietary technology platform that offers new levels of energy density and performance. It is backed financially by Tesla co-founders Marc Tarpenning and Martin Eberhard.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT